
Healthcare / Pharmaceuticals · BSE
Amwill Health Care Limited, founded in 2017, specializes in skincare, haircare, personal care, hygiene, and lip care products. The company focuses on innovative dermatological and cosmetic solutions but doesn’t manufacture products itself. Instead, it partners with third parties for production, testing, and distribution. Amwill sells exclusively to Amderma Healthcare LLP, which handles storage and order fulfillment. Currently operating in Karnataka, Andhra Pradesh, and Telangana, the company plans to expand to West Bengal and Odisha. With a team of 59 professionals, Amwill covers product development, marketing, sales, and administration.
Price Band
₹105 – ₹111
Issue Size
₹59.98 Cr
Lot Size
1200 shares
GMP
Est. Listing
₹111
at current GMP
Subscribed
5.78x
overall
Open
5 Feb 2025
Close
7 Feb 2025
Allotment
10 Feb 2025
Refund
11 Feb 2025
Demat Credit
12 Feb 2025
Listing
12 Feb 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹111
Band: ₹105 – ₹111
Estimated Listing Price
₹111
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,33,200
Estimated Profit / Lot
₹0
1200 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹111 |
| 30 Oct 2026 | — | 0.0% | ₹111 |
| 29 Oct 2026 | — | 0.0% | ₹111 |
GMP is unofficial market data. Not a guarantee of listing performance.
Amwill Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹59.98 Crores. The shares are offered at a price band of ₹105 to ₹111 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,33,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-02-12, while un-allotted funds or UPI block mandates will be released on 2025-02-11.
The latest grey market premium for Amwill Healthcare Limited IPO is ₹0, which indicates an expected listing price of ₹111.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.